Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

An update on a Phase 1 study examining the pharmacokinetics, safety, and preliminary efficacy of BIIL 284 BS in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BIIL 284 BS

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED